[AP-01] Poster Presentation Award Session（ Basic Research）

[AP-01-5] Novel binding partner of dysferlin is a potential therapeutic target for dysferlinopathy

^○Hiroya Ono¹, Naoki Suzuki¹, Shin-ichiro Kanno², Genri Kawahara³, Rumiko Izumi¹, Toshiaki Takahashi⁴, Yasuo Kitajima⁵, Shion Osana⁶, Tetsuya Akiyama¹, Kensuke Ikeda¹, Tomomi Shijo¹, Shio Mitsuzawa¹, Hitoshi Warita¹, Ryoichi Nagatomi⁶, Nobukazu Araki⁷, Akira Yasui², Yukiko K. Hayashi³, Katsuya Miyake^7,8, Masashi Aoki¹ (1.Department of Neurology, Tohoku University School of Medicine, 2.The Institute of Development, Aging and Cancer, Tohoku University, 3.Department of Pathophysiology, Tokyo Medical University, 4.National Hospital Organization Sendai-Nishitaga National Hospital, 5.Department of Stem Cell Biology, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, 6.Division of Biomedical Engineering for Health and Welfare, Tohoku University Graduate School of Biomedical Engineering, 7.Department of Histology and Cell Biology, Faculty of Medicine, Kagawa University, 8.Institute of Basic Medical Research, International University of Health and Welfare)